ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it will display a number of new products and clinical solutions from the company’s Cardiac Rhythm Management (CRM) and Atrial Fibrillation (AF) Divisions at Heart Rhythm 2010, the Heart Rhythm Society’s 31st Annual Scientific Sessions. The new products highlight the company’s commitment to providing the most comprehensive and technologically advanced portfolio of therapies and devices for the treatment of heart arrhythmias, including products that enhance connectivity.
